Alum David Bearss is now the chief executive officer of Lehi-based biotech firm Tolero Pharmaceuticals, whose team of scientists is conducting clinical trials on a drug that has shown promise in treating acute myeloid leukemia, or AML. Read More →
Watch the videos from UT Health Voices 2017 featuring speakers from each of the five schools at The University of Texas Health Science Center at San Antonio. Read More →